![Robert Hayes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Robert Hayes served as the Executive Director & Chief Scientific Officer at PYC Therapeutics Ltd. from 2017 to 2018.
Prior to that, he was the Senior Director-Protein Engineering at Johnson & Johnson (Austrial) Pty Ltd. and the Biologics Head at Amgen Australia Pty Ltd. Hayes holds a doctorate degree from Imperial College London and a graduate degree from University College London.
Eerdere bekende functies van Robert Hayes
| Bedrijven | Functie | Einde |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Hoofd Techniek/Wetenschap/O&O | 30-11-2018 |
Johnson & Johnson (Austrial) Pty Ltd. | Corporate Officer/Principal | - |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Opleiding van Robert Hayes
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Australia Pty Ltd. | |
Johnson & Johnson (Austrial) Pty Ltd. |
